Immatics NV (IMTX)
9.95
-0.35
(-3.40%)
USD |
NASDAQ |
Feb 10, 16:00
9.95
0.00 (0.00%)
After-Hours: 20:00
Immatics Shareholders Equity (Quarterly) : 489.60M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CureVac NV | 1.024B |
| Bayer AG | 34.75B |
| MediGene AG | -- |
| InflaRx NV | 53.31M |
| BioNTech SE | 21.71B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 609.30M |
| Total Liabilities (Quarterly) | 119.71M |
| Debt to Equity Ratio | 0.0393 |
| Current Ratio | 7.357 |
| Net Debt Paydown Yield | 0.37% |